Real-Time Definition of Non-Randomness in the Distribution of Genomic Events

• Ulrich Abel,

  Affiliations Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany, Department of Medical Biostatistics, Tumor Center Heidelberg-Mannheim, Heidelberg, Germany

  ⨯
• Annette Deichmann,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Cynthia Bartholomae,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Kerstin Schwarzwaelder,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Hanno Glimm,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Steven Howe,

  Affiliation Department of Medical Biostatistics, Tumor Center Heidelberg-Mannheim, Heidelberg, Germany

  ⨯
• Adrian Thrasher,

  Affiliations Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom, Department of Clinical Immunology, Great Ormond Street Hospital NHS Trust, London, United Kingdom

  ⨯
• Alexandrine Garrigue,

  Affiliation INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France

  ⨯
• Salima Hacein-Bey-Abina,

  Affiliations INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France, Département de Biothérapies, Hôpital Necker, Paris, France

  ⨯
• Marina Cavazzana-Calvo,

  Affiliations INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France, Département de Biothérapies, Hôpital Necker, Paris, France

  ⨯
• Alain Fischer,

  Affiliations INSERM Unit 768, Hôpital Necker and Faculté de Médecine Université René Descartes Paris V., Paris, France, Unité d'Immunologie et d'Hématologie Pédiatriques, Hôpital Necker, Paris, France

  ⨯
• Dirk Jaeger,

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯
• Christof von Kalle ,

  *To whom correspondence should be addressed. E-mail: christof.kalle@nct-heidelberg.de (CK); manfred.schmidt@nct-heidelberg.de (MS)

  Affiliations Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany, Division of Experimental Hematology, Cincinnati Childrens Research Foundation, Cincinnati, Ohio, United States of America

  ⨯
• Manfred Schmidt

  *To whom correspondence should be addressed. E-mail: christof.kalle@nct-heidelberg.de (CK); manfred.schmidt@nct-heidelberg.de (MS)

  Affiliation Department of Translational Oncology, National Center for Tumor Diseases, Heidelberg, Germany

  ⨯